P0117 PSMA-targeted silicasome co-delivery of rucaparib and tazemetostat enhances synergistic treatment of metastatic castration-resistant prostate cancer

European Urology 2026

View at publisher

Authors: Q. Huang, Y. Bi, X. Liu, M. Zhang

DOI: 10.1016/s0302-2838(26)01028-6

Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Nanoparticle-Based Drug Delivery PARP inhibition in cancer therapy